Observing patients undergoing bariatric surgery
The Patient Cohort for Bariatric Surgery
This study looks at how different types of care can help patients before and after bariatric surgery to see if it can improve their health and reduce complications.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 16 Years to 65 Years |
| Sex | All |
| Sponsor | China-Japan Friendship Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06452303 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the comprehensive management of bariatric surgery by integrating various disciplines such as general surgery, endocrinology, nutrition, exercise, and traditional Chinese medicine. It aims to record key health indicators of patients before and after surgery and employs machine learning techniques to predict postoperative complications. The ultimate goal is to enhance precision management and establish a refined diagnosis and treatment system for metabolic weight loss surgery, thereby improving patient outcomes and reducing healthcare burdens.
Who should consider this trial
Good fit: Ideal candidates include individuals with simple obesity or type 2 diabetes who have not achieved adequate control through lifestyle changes or medical treatment.
Not a fit: Patients with non-obese type 1 diabetes or those with significant loss of pancreatic function may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and outcomes for patients undergoing bariatric surgery.
How similar studies have performed: Other studies have shown success in using integrated approaches for managing bariatric surgery, but this specific methodology may be novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1、For those with simple obesity, BMI ≥ 32.5, or 27.5 ≤ BMI \< 32.5, who have difficulty controlling their condition with lifestyle modifications and medical treatment, and who meet at least two criteria for metabolic syndrome components, or have comorbidities. 2、For those with simple obesity, 27.5 ≤ BMI \< 32.5, and with male waist circumference ≥ 90 cm, female waist circumference ≥ 85 cm, and imaging studies suggesting central obesity. 3、For those with type 2 diabetes, BMI ≥ 27.5, who still have some residual insulin secretion capacity. Exclusion Criteria: * 1、Non-obese type 1 diabetes; 2、Those for whom the purpose of treatment is T2DM, but whose pancreatic beta-cell function is largely lost, with a BMI \< 25.0; 3、Age \< 16 years or age \> 65 years; 4、Pregnant women with diabetes and patients with certain special types of diabetes; 5、Those with a cognitive disorder or immature intelligence, and who cannot control their behavior; 6、Those whose expectations for the surgery are not realistic; 7、Those unwilling to assume the risks of potential surgical complications; 8、Those unable to comply with postoperative dietary and lifestyle changes, showing poor compliance; 9、Those in poor general health, who are unable to tolerate general anesthesia or surgery.
Where this trial is running
Beijing, Beijing Municipality
- China-Japan Friendship Hospital — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Study coordinator: Hua Meng, doctor
- Email: menghuade@hotmail.com
- Phone: 18611457779
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.